Lodo Therapeutics (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- January 11, 2016
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $17,000,000
Company Info
- Founders
- Sean Brady, David Pompliano
- Company Description
- Lodo Therapeutics seeks to realize the vision of researcher and co-founder Sean Brady, Ph.D., focusing on the discovery, biosynthesis, and characterization of new, genetically-encoded small molecules from microbial sources, particularly from uncultured soil bacteria and the human microbiome.
- Market
- Pharmaceuticals
- Location
- New York, NY, USA
- Coinvestors
- AbbVie Biotech Ventures, Accelerator, Alexandria Real Estate Equities, ARCH Venture Partners, Eli Lilly and Company, Harris & Harris Group, Innovate NY Fund, Johnson & Johnson Development Corporation (JJDC), Pfizer Strategic Investments Group, The Partnership for New York City Fund, Watson Fund, WuXi Corporate Venture Fund